Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent

Henricus J. Duckers1*, MD, PhD; Sigmund Silber2 MD PhD; Robbert de Winter3, MD, PhD; Peter den Heijer4, MD, PhD; Benno Rensing5, MD, PhD; Matthias Rau6, MD, PhD; Harald Mudra7, MD, PhD; Edouard Benit8, MD, PhD; Stefan Verheye9, MD, PhD; William Wijns10, MD, PhD; Patrick W. Serruys1, MD, PhD

1. Thoraxcenter, Erasmus University Medical Center Rotterdam, The Netherlands; 2. Kardiologische Klinik Dr. Müller München, Germany; 3. Academisch Medisch Centrum, Amsterdam, The Netherlands; 4. Amphia Ziekenhuis, Breda, The Netherlands; 5. Sint Antonius

Aims: In contrast to the cytostatic and cytotoxic pharmacotherapy of drug eluting stents, approaches to stimulate the arterial healing response by accelerating re-endothelialisation may be an attractive alternati

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

endothelial progenitor cell/ epcangioplastystent-related restenosisbioengineered stent technologyendotheliumpro-healing concept

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Intracoronary administration of cells derived from bone marrow in acute myocardial infarction. Ready for clinical use? Lessons from the ASTAMI trial